Reference is made notice published by Bionor Pharma ASA (OSE:BIONOR) 13 September 2013 regarding private placement of new shares with gross proceeds of NOK 54.45 million. The share capital increase was registered in the Norwegian Register of Business Enterprises (Foretaksregisteret) 20.09.13. The Company's new share capital after registration is NOK NOK 54,581,587 comprising 218,326,348 shares with a par value of NOK 0.25.
Bionor Pharma ASA
Synne H Røine
CFO
Tel +47 99 22 98 92
This information is subject of the disclosure requirements acc. to §5-12 vphl (Norwegian Securities Trading Act).